Healthcare -
Biotechnology - NASDAQ - US
$ 19.14
-1.8 %
$ 1.36 B
Market Cap
-6.6
P/E
NRIX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NRIX - Nurix Therapeutics, Inc.
3.22 M
LAST VALUE
-85.54%
2 YEAR CAGR
43.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR